Status:

COMPLETED

Dermacyd Femina Pocket BR (Lactic Acid)- Acceptability.

Lead Sponsor:

Sanofi

Conditions:

Hygiene

Eligibility:

FEMALE

18-60 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to prove the safety of the gynaecological formulation in normal conditions of use.

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Integral skin test in the region;
  • To use products of the same category;
  • Exclusion criteria:
  • Lactation or gestation;
  • Use of anti-inflammatory, anti-histaminic or immunosuppressant drugs;
  • Cutaneous disease (local or spread) in the evaluation area;
  • Pathology which may cause immunity depression, such as HIV, diabetes;
  • Endocrine pathology
  • Solar exposure 15 days before evaluation;
  • Treatment until four months before the selection.
  • Allergic or atopic history to cosmetics products
  • The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Exclusion

    Key Trial Info

    Start Date :

    November 1 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    Estimated Enrollment :

    30 Patients enrolled

    Trial Details

    Trial ID

    NCT00794612

    Start Date

    November 1 2008

    Last Update

    December 19 2008

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Sanofi-Aventis Administrative Office

    São Paulo, Brazil